Company Filing History:
Years Active: 2009
Title: Lorna Ehrlich: Innovator in HIV Research
Introduction
Lorna Ehrlich is a prominent inventor based in Shoreham, NY (US). She has made significant contributions to the field of biomedical research, particularly in the fight against HIV. Her innovative work has led to the development of methods that could potentially inhibit HIV production.
Latest Patents
Lorna Ehrlich holds a patent for an invention titled "Assay for TSG101 as inhibitors of HIV production." This invention provides methods for identifying peptides in a mammalian Tsg101 protein that binds to the PTAPP motif or L domain of human immunodeficiency virus type I (HIV-1). Such peptides can be utilized to inhibit Tsg101-HIV Gag binding, effectively reducing HIV particle production. The invention also encompasses the peptides identified by this method and outlines their use for treating HIV infection. She has 1 patent to her name.
Career Highlights
Ehrlich's career has been marked by her dedication to advancing scientific knowledge and developing practical solutions for complex health issues. Her work has garnered attention in the scientific community, showcasing her commitment to improving health outcomes for individuals affected by HIV.
Collaborations
Lorna has collaborated with notable colleagues, including Carol Carter and Arthur Goff. These partnerships have further enriched her research and contributed to the advancement of her innovative projects.
Conclusion
Lorna Ehrlich's contributions to HIV research exemplify the impact of innovation in the medical field. Her patented methods offer hope for new treatments and demonstrate the importance of continued research in combating viral infections.